Jardiance vs Ozempic
Side-by-side cost comparison based on Medicare Part D data
Jardiance
Empagliflozin
Manufactured by Boehringer Ingelheim
Ozempic
Semaglutide
Manufactured by Novo Nordisk
Jardiance costs 69% less per claim than Ozempic ($210.00 vs $685.00). A generic version of Jardiance is also available, which may reduce costs further.
Cost Per Claim
Medicare Spending
Beneficiaries
Annual Cost Per Patient
Full Comparison
| Metric | Jardiance | Ozempic |
|---|---|---|
| Avg Cost Per Claim | $210.00 | $685.00 |
| Total Medicare Spending | $3.9B | $5.0B |
| Total Beneficiaries | 2,150,000 | 1,180,000 |
| Total Claims | 18,760,000 | 7,240,000 |
| Annual Cost/Patient | $1,835.00 | $4,200.00 |
| Year-over-Year Change | +22.7% | +72.5% |
| Generic Available | Yes | No |
| Patent Expiration | May 23, 2025 | Sep 20, 2031 |
| Manufacturer | Boehringer Ingelheim | Novo Nordisk |
| Condition | Diabetes | Diabetes |
| Generic Name | Empagliflozin | Semaglutide |
Jardiance vs Ozempic: What the Data Shows
Jardiance (Empagliflozin) and Ozempic (Semaglutide) are both used to treat diabetes. Based on Medicare Part D data, Jardiance costs $210.00 per claim, which is 69% less than Ozempic at $685.00 per claim.
Medicare spent $3.9B on Jardiance and $5.0B on Ozempic. In terms of patient reach, Jardiance serves more beneficiaries (2,150,000 vs 1,180,000).
Year-over-year spending changed +22.7% for Jardiance and +72.5% for Ozempic. Jardiance saw significant spending growth, suggesting increased utilization or price increases. Ozempic saw significant spending growth, suggesting increased utilization or price increases.
Jardiance has a generic available, while Ozempic remains brand-only until its patent expires Sep 20, 2031.
Frequently Asked Questions
Jardiance is cheaper at $210.00 per claim, compared to $685.00 for Ozempic. That makes Jardiance about 69% less expensive per claim based on Medicare Part D data.
Yes, both Jardiance and Ozempic are used to treat diabetes. Your doctor can help determine which medication is more appropriate for your specific situation.
Jardiance has a generic version (Empagliflozin) available, which is typically much cheaper. Ozempic is currently brand-only, with patent expiring Sep 20, 2031.
Medicare Part D spent $3.9B on Jardiance covering 2,150,000 beneficiaries, and $5.0B on Ozempic covering 1,180,000 beneficiaries.
Explore Further
Cost data reflects Medicare Part D spending and may not represent retail pharmacy prices. Average cost per claim represents the total drug cost (not patient out-of-pocket) divided by total claims. This comparison is informational only and should not replace medical advice.